山东大学耳鼻喉眼学报 ›› 2021, Vol. 35 ›› Issue (1): 47-55.doi: 10.6040/j.issn.1673-3770.0.2020.181

• • 上一篇    下一篇

内舒拿联合孟鲁司特钠治疗腺样体肥大的Meta分析

谷婷婷,刘岩,张悦,于丹,文连姬   

  1. 吉林大学第二医院 耳鼻咽喉头颈外科, 吉林 长春 130022
  • 发布日期:2021-02-01
  • 通讯作者: 文连姬. E-mail:wlj_3859@163.com
  • 基金资助:
    吉林省自然科学基金(20200201455JC)

Nasonex and montelukast sodium in the treatment of adenoidal hypertrophy: a Meta-analysis

GU Tingting, LIU Yan, ZHANG Yue, YU Dan, WEN Lianji   

  1. Department of Otorhinolaryngology & Head and Neck surgery, The Second Hospital of Jilin University, Changchun 130022, Jilin, China
  • Published:2021-02-01

PDF (PC)

431

摘要： 目的 评价内舒拿联合孟鲁司特钠治疗儿童腺样体肥大的疗效。 方法 系统检索PubMed、万方、中国知网、维普网数据库2010~2020年内舒拿联合孟鲁司特钠治疗小儿腺样体肥大的相关文献。按照纳入和排除标准进行筛选文献,使用“Cochrane 偏倚风险评估”工具进行文献质量评价,对纳入文献采用RevMan 5.3 软件进行META分析。该研究共 10篇文献入选META分析,总样本量865例。 结果 统计数据表明内舒拿联合孟鲁司特钠(以下称为联合用药)治疗儿童腺样体肥大总有效率高于单纯使用内舒拿(以下称为单药)治疗,差异具有统计学意义(OR=4.29, 95%CI［2.72,6.77］,P<0.000 01)。对于缩小鼻咽部侧位片腺样体厚度与鼻咽腔前后径宽度的比值(A/N)优于单纯使用内舒拿治疗,差异具有统计学意义(MD=-0.06, 95%CI［-0.10, -0.03］,P<0.000 1)对于缓解临床症状积分效果优于单药组,差异具有统计学意义(MD=-1.40, 95%CI［-1.57, -1.23］,P<0.000 01),对睡眠质量改善优于单药组,差距具有统计学意义(MD=-1.40, 95%CI［-1.60, -1.20］,P<0.000 01),对于日常功能的影响小于单药组,差距具有统计学意义(MD=-1.07, 95%CI［-1.22, -0.93］, P<0.000 01)。 结论 基于目前的研究和分析,内舒拿联合孟鲁司特钠治疗儿童腺样体肥大具有显著的临床疗效,缓解各种临床症状及缩小腺样体体积明显优于单纯使用内舒拿治疗,文献均未报道明显的不良反应。

关键词: 腺样体肥大, 孟鲁司特钠(顺尔宁), 内舒拿, 有效率, 随机对照实验

Abstract: Objective To evaluate the efficacy of Nasonex and montelukast sodium in the treatment of adenoidal hypertrophy. Methods We conducted a systematic literature search of Pub Med, Wangfang, and the Chinese National Knowledge VIP database 2010-2020 for Nasonex and montelukast sodium treatment in children with adenoidal hypertrophy. Standard articles were screened according to inclusion and exclusion criteria. The methodological quality of trials was evaluated with the Cochrane Handbook criteria, and the Review Manager 5.3 Revman5.1 software used for Meta-analyses. Finally, eleven articles, describing 865 patients, were selected, and included in the meta-analysis. Results The meta-analysis showed that the total effective rate of Nasonex combined with montelukast sodium(“the combination drug”)was significantly higher than that of Nasonex alone(“the single drug”)in the treatment of adenoidal hypertrophy in children(OR=4.29, 95%CI［2.72, 6.77］, P<0.000 01). The combination drug also caused a significant decrease in the A/N ratio(adeniod/nasopharynx ratio))(MD =-0.06, 95%CI［-0.10, -0.03］, P<0.000 1), and lowered clinical symptoms(MD=-1.40, 95%CI［-1.57, -1.23］). The combination drug significantly improved the quality of sleep in comparison to the single drug(MD=-1.40, 95%CI［-1.60, -1.20］, P<0.000 01). The combination group also demonstrated lower effects on the impact on daily functioning than the single drug group(MD=-1.07, 95%CI［-1.22, -0.93］, P<0.000 01). Conclusion Based on the current research and analysis, Nasonex combined with montelukast sodium has a significant clinical effect in the treatment of adenoidal hypertrophy in children. It is also a better choice to relieve various clinical symptoms and reduce the volume of adenoids than Nasonex alone. There was no literature that reported obvious adverse reactions.

Key words: Adenoidal hypertrophy in children, Nasonex, Montelukast(singular), Effective rate, Randomized controlled trial

中图分类号: 

  • R766.18
[1] 刘燕, 魏萍, 寇巍, 等. 儿童腺样体肥大与耳鼻咽喉科常见疾病关系的研究进展[J]. 山东大学耳鼻喉眼学报, 2019, 33(4): 149-154. doi: 10.6040/j.issn.1673-3770.0.2018.266. LIU Yan, WEI Ping, KOU Wei, et al. Research of the relationship between adenoid hypertrophy and the common diseases of pediatric otolaryngology[J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2019, 33(4): 149-154. doi: 10.6040/j.issn.1673-3770.0.2018.266.
[2] 常丽,王玉平,陈超,等. 阻塞性睡眠呼吸暂停低通气综合征患儿发生行为和注意力问题的可能性研究[J]. 中华全科医师杂志, 2016(7): 546-549. doi: 10.3760/cma.j.issn.1671-7368.2016.07.013. CHANG Li, WANG Yuping, CHEN Chao, et al. Behavior and attention problems in children with obstructive sleep apnea and hypopnea syndrome[J]. Chinese JOurnal of General Practitioners, 2016(7): 546-549. doi: 10.3760/cma.j.issn.1671-7368.2016.07.013.
[3] 中华耳鼻咽喉头颈外科杂志编委会, 中华医学会耳鼻咽喉科学分会.儿童阻塞性睡眠呼吸暂停低通气综合征诊疗指南草案(乌鲁木齐)[J]. 中华耳鼻咽喉头颈外科杂志, 2007, 42(2): 83-84. doi: 10.3760/j.issn:1673-0860.2007.02.002.
[4] 刘见英. 孟鲁司特联合糠酸莫米松鼻喷雾剂治疗儿童腺样体肥大的临床研究[J]. 世界最新医学信息文摘(电子版), 2018, 18(42): 122-122, 283. doi: 10.19613/j.cnki.1671-3141.2018.42.088.
[5] 吴右彬. 孟鲁司特联合糠酸莫米松鼻喷雾剂治疗腺样体肥大的疗效分析[J]. 按摩与康复医学, 2018, 9(20): 37-38. Doi: CNKI:SUN:AMYD.0.2018-20-018.
[6] 王晓东,乾恩乐. 孟鲁司特联合糠酸莫米松鼻喷雾剂治疗小儿腺样体肥大临床疗效[J]. 深圳中西医结合杂志, 2018, 28(5): 25-26. doi: 10.16458/j.cnki.1007-0893.2018.05.011.
[7] 王生华. 孟鲁司特钠联合糠酸莫米松鼻喷剂治疗小儿腺样体肥大的临床研究[J]. 北方药学, 2019, 16(6): 86-87. doi: CNKI:SUN:BFYX.0.2019-06-069.
[8] 刘炜, 陈仁杰. 糠酸莫米松鼻喷剂联合孟鲁司特钠治疗儿童腺样体肥大的疗效观察[J]. 临床耳鼻咽喉头颈外科杂志, 2017(5): 366-368, 373. doi: 10.ssss/j.issn.1001-1781.2017.5.008. LIU Wei, CHEN Renjie. Clinical observation of mometasone furoate nasal spray combined with montelukast sodium in the treatment of adenoid hypertrophy in children[J]. Journal of Clinical Otorhinolaryngology, 2017(5): 366-368, 373. doi: 10.ssss/j.issn.1001-1781.2017.5.008.
[9] 李清波, 程坚, 苏文宇. 孟鲁司特钠联合糠酸莫米松鼻喷雾剂治疗小儿腺样体肥大疗效观察[J]. 国际医药卫生导报,2013, 19(9): 1297-1297. doi: 10.3760/cma.j.issn.1007-1245.2013.09.028.
[10] 廖海石, 冯剑华, 苏宏钊, 等. 孟鲁司特钠联合糠酸莫米松鼻喷剂治疗儿童腺样体肥大的临床效果[J]. 中国当代医药, 2019, 26(32): 152-154. LIAO Haishi, FENG Jianhua, SU Hongzhao, et al. Clinical effect of montelukast sodium combined with mometasone furoate nasal spray in the treatment of pediatric adenoid hypertrophy[J]. China Modern Medicine, 2019, 26(32): 152-154.
[11] 李庆忠. 孟鲁司特联合糠酸莫米松鼻喷雾剂治疗小儿腺样体肥大的效果观察[J]. 饮食保健(药物与临床), 2016, 2(23):75. doi: 10.3969/j.issn.2095-8439.2016.23.068.
[12] 胡全福, 欧阳绍基, 姚榕威, 等. 孟鲁司特钠联合糠酸莫米松鼻喷雾剂对腺样体肥大患儿生活质量的影响[J]. 云南医药, 2018, 39(3): 251-253.
[13] Tuhanıo glu B, Erkan SO. Evaluation of the effects of montelukast, mometasone furoate, and combined therapyon adenoid size: a randomized, prospective, clinical trial with objective data[J]. Turk J Med Sci, 2017, 47(6): 1736-1743. doi:10.3906/sag-1701-179.
[14] Franco RA Jr, Rosenfeld RM, Rao M. First place: resident clinical science award 1999. Quality of life for children with obstructive sleep apnea[J]. Otolaryngol Head Neck Surg, 2000, 123(1 Pt 1): 9-16. doi:10.1067/mhn.2000.105254.
[15] de Serres LM, Derkay C, Astley S, et al. Measuring quality of life in children with obstructive sleep disorders[J]. Arch Otolaryngol Head Neck Surg, 2000, 126(12): 1423-1429. doi:10.1001/archotol.126.12.1423.
[16] 龙朝庆, 颜永毅, 容庆丰. OSA-18量表评估腺样体肥大儿童生活质量.[J]. 山东大学耳鼻喉眼学报, 2015(4):13-15. doi: 10.6040/j.issn.1673-3770.0.2014.419. LONG Chaoqing, YAN Yongyi, RONG Qingfeng. Assessment of quality of life in children with adenoid hypertrophy by OSA-18 questionnaire[J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2015(4):13-15. doi: 10.6040/j.issn.1673-3770.0.2014.419.
[17] Cassano P, Gelardi M, Cassano M, et al. Adenoid tissue rhinopharyngeal obstruction grading based on fiberendoscopic findings: a novel approach to therapeutic management[J]. Int J Pediatr Otorhinolaryngol, 2003, 67(12): 1303-1309. doi:10.1016/j.ijporl.2003.07.018.
[18] Spada F, Barnes TM, Greive KA. Comparative safety and efficacy of topical mometasone furoate with other topical corticosteroids[J]. Australas J Dermatol, 2018, 59(3): e168-e174. doi:10.1111/ajd.12762.
[19] 梁敏, 朱美华, 温红艳, 等. 孟鲁司特治疗儿童不同病因腺样体肥大的效果比较[J]. 广东医学, 2014, 35(18): 2915-2917. doi: 10.3969/j.issn.1001-9448.2014.18.039.
[20] 谭杰武.孟鲁司特钠在小儿腺样体肥大中的应用疗效观察[J].黑龙江医药,2019,48(4):86-87.
[21] 崔佳文,顾非,王怡超,等. 腺样体肥大检测手段的进展和评价[J]. 中医眼耳鼻喉杂志,2019,9(3):175-178.
[22] 史雪溶.分析X线影像学检查对儿童腺样体肥大的诊断[J]. 影像技术,2018,5(09),37-38,36.
[23] 邓莹莹,陈观尚,郑启文,等. CT和MRI在检查儿童腺样体肥大(AH)中的价值比较[J].现代医用影像学,2019(12):2651-2653.
[24] Cameron A Todd. Adenotonsillectomy for Obstructive Sleep Apnea and Quality of Life: Systematic Review and Meta-analysis [J].Otolaryngol Head Neck Surg, 2017, 157(5):767-773.
[25] 李娟, 程杰, 何艳. 鼻腔冲洗联合糠酸莫米松鼻喷雾剂治疗变应性鼻炎的疗效观察[J]. 重庆医学, 2016, 45(25): 3506-3507, 3513. doi: 10.3969/j.issn.1671-8348.2016.25.017. LI Juan, CHENG Jie, HE Yan. The efficacy of nasal irrigation with mometasone furoate aqueous nasal spray on allergic rhinitis[J]. Chongqing Medical Journal, 2016, 45(25): 3506-3507, 3513. doi: 10.3969/j.issn.1671-8348.2016.25.017.
[26] 陈瑜萍, 李其兴. 药物性鼻炎应用糠酸莫米松鼻喷雾剂治疗效果分析[J]. 中外医学研究, 2019, 17(25): 148-150. doi: 10.14033/j.cnki.cfmr.2019.25.063. CHEN Yuping, LI Qixing. Therapeutic effect of mometasone furoate nasal spray on drug-induced rhinitis[J]. Chinese and foreign medical research, 2019, 17(25): 148-150. doi: 10.14033/j.cnki.cfmr.2019.25.063.
[27] 孙蕾. 糠酸莫米松鼻用喷雾剂治疗变应性鼻炎的临床效果及安全性[J]. 系统医学, 2019, 4(20): 143-154. doi: 10.19368/j.cnki.2096-1782.2019.20.143. SUN Lei. Clinical effect and safety of mometasone furoate nasal spray in the treatment of allergic rhinitis[J]. Systems Medicine, 2019, 4(20): 143-154. doi: 10.19368/j.cnki.2096-1782.2019.20.143.
[28] 吴光华, 魏涵, 闫聪聪, 等. 孟鲁司特钠致儿童不良反应文献分析[J]. 儿科药学杂志, 2019, 25(5): 43-46. doi: CNKI:SUN:EKYX.0.2019-05-017. WU Guanghua, WEI Han, YAN Congcong, et al. Literature analysis of pediatric adverse drug reactions induced by montelukast sodium[J]. Journal of Pediatric Pharmacy, 2019, 25(5): 43-46. doi: CNKI:SUN:EKYX.0.2019-05-017.
[1] 王兴鑫,杨欣雨,郑晓军,丁麟,盛亚文,毕晓云,杨继国. 穴位贴敷疗法治疗小儿腺样体肥大1例[J]. 山东大学耳鼻喉眼学报, 2022, 36(5): 122-124.
[2] 金霄雪,韩莹莹,郭瑞祥,倪守洁,邹娟娟,王岩,李延忠. 替牙期扁桃体伴腺样体肥大患儿过敏因素与颌面畸形的相关性[J]. 山东大学耳鼻喉眼学报, 2022, 36(2): 45-50.
[3] 袁晨阳, 刘燕, 房振胜. 儿童阻塞性睡眠呼吸暂停低通气综合征对肺功能的影响[J]. 山东大学耳鼻喉眼学报, 2022, 36(1): 143-148.
[4] 钟丽萍,官希龙,王晶晶,汤勇. 鼓室与全身应用激素治疗突发性耳聋的系统评价与Meta分析[J]. 山东大学耳鼻喉眼学报, 2021, 35(5): 1-10.
[5] 林小燕,李静,马志祺,李依琳,高馨怡,李勇. 益生菌治疗变应性鼻炎的临床疗效及抗变态反应作用Meta分析[J]. 山东大学耳鼻喉眼学报, 2021, 35(3): 70-80.
[6] 吴华,孙永明,郑建华,蔡雪花. 腺样体消融联合鼓膜打孔术治疗儿童腺样体肥大合并分泌性中耳炎55例[J]. 山东大学耳鼻喉眼学报, 2021, 35(2): 71-75.
[7] 张立强. 儿童鼻窦炎与腺样体肥大的关系[J]. 山东大学耳鼻喉眼学报, 2019, 33(6): 25-28.
[8] 刘燕,魏萍,寇巍,胡思洁,武小芳,刘萌雅,陈成,姚红兵. 儿童腺样体肥大与耳鼻咽喉科常见疾病关系的研究进展[J]. 山东大学耳鼻喉眼学报, 2019, 33(4): 149-154.
[9] 王驰,刘星,孔磊,洪兴和,宁博. 鼻内镜下等离子射频消融术对合并鼻窦炎的小儿腺样体肥大患者疗效及鼻腔黏膜纤毛清除功能的影响[J]. 山东大学耳鼻喉眼学报, 2018, 32(5): 78-81.
[10] 周鼎坤,蔡郁,田艳华,滕博,冯青杰. Crouzon儿童腺样体切除术后并发Grisel综合征一例[J]. 山东大学耳鼻喉眼学报, 2018, 32(5): 119-120.
[11] 王岩,师晓丽. 变态反应与儿童OSAHS的关系[J]. 山东大学耳鼻喉眼学报, 2018, 32(2): 14-18.
[12] 高进良,年婉清,李烁. 鼻内镜手术联合鼻用糖皮质激素治疗腺样体肥大性[J]. 山东大学耳鼻喉眼学报, 2018, 32(2): 38-42.
[13] 谢日林,张志平. 布地奈德体位滴鼻治疗伴腺样体肥大的小儿分泌性中耳炎31例[J]. 山东大学耳鼻喉眼学报, 2018, 32(1): 65-67.
[14] 刘洁,施陈燕,张治军. 糠酸莫米松鼻喷剂联合玉屏风颗粒可提高儿童腺样体肥大疗效[J]. 山东大学耳鼻喉眼学报, 2017, 31(2): 73-76.
[15] 龙朝庆, 颜永毅, 容庆丰. OSA-18量表评估腺样体肥大儿童生活质量[J]. 山东大学耳鼻喉眼学报, 2015, 29(3): 13-15.
Viewed
Full text


Abstract

Cited
  Shared   
  Discussed   
[1] 张晗,黄一飞 . 抗角膜移植排斥的研究进展[J]. 山东大学耳鼻喉眼学报, 2006, 20(1): 84 -87 .
[2] 牛善利,柴茂文,李振秀 . 鼻内镜下鼻甲成形术治疗慢性肥厚性鼻炎60例[J]. 山东大学耳鼻喉眼学报, 2006, 20(1): 16 -18 .
[3] 孟庆国,卢永田,范献良 . 杀伤细胞免疫球蛋白样受体基因多态性与鼻咽癌的关联性[J]. 山东大学耳鼻喉眼学报, 2008, 22(3): 196 -199 .
[4] 马玉起,孔祥春 . 先天性双侧下唇窦道1例[J]. 山东大学耳鼻喉眼学报, 2008, 22(3): 199 -199 .
[5] 万俐佳,鲁海涛,姜义道,刘 辉,李 琴,佘腊枝 . 改良腭咽成形术治疗阻塞性睡眠呼吸暂停综合征41例[J]. 山东大学耳鼻喉眼学报, 2008, 22(3): 204 -205 .
[6] 于青青 ,王跃建 . 硬质耳内镜的临床应用进展[J]. 山东大学耳鼻喉眼学报, 2008, 22(3): 222 -224 .
[7] 吉晓滨,邓家德,臧林泉,王 磊,谢 军 . 豚鼠变应性鼻炎模型血清组胺的测定[J]. 山东大学耳鼻喉眼学报, 2008, 22(3): 228 -230 .
[8] 向登,卢永田,孙焕吉 . 鼻内镜下修补脑脊液鼻漏19例并文献复习[J]. 山东大学耳鼻喉眼学报, 2008, 22(3): 234 -236 .
[9] 邱恩惠,李志春,方文旭 . 嗅觉障碍的中西医治疗[J]. 山东大学耳鼻喉眼学报, 2008, 22(3): 253 -257 .
[10] 殷国华,钟 笑 . 激光减容术治疗舌扁桃体肥大的远期疗效[J]. 山东大学耳鼻喉眼学报, 2008, 22(3): 280 -282 .
网站版权所有 © 2018 《山东大学耳鼻喉眼学报》编辑部　
地址：山东省济南市山大南路27号（250100）电话：+86-0531-88366912 E-mail: ebhxb@sdu.edu.cn
本系统由北京玛格泰克科技发展有限公司设计开发